Novo Nordisk

Page 3 of 9

Eli Lilly & Co., the Fortune 500 pharma firm that manufactures weight-loss injection Zepbound (tirzepatide), has a comparable oral medication in the works that could be approved by the FDA as early as 2026, CEO Dave Ricks told Bloomberg TV on Jan. 13, 2025.
Health

Hate needles? Lilly’s weight-loss pill could get FDA approval next year, CEO says

By
January 22, 2025
Chairman & Chief Executive Officer of LVMH, Bernard Arnault attends the Viva Technology show at Parc des Expositions Porte de Versailles on May 23, 2024 in Paris, France.
Success

LVMH dethrones Novo Nordisk as Europe’s most valuable company as Bernard Arnault adds $12 billion to net worth in 2025

By
January 20, 2025
Danish Prime Minister Mette Frederiksen (R) and Greenlandic Prime Minister Mute Bourup Egede address a press conference in the Mirror Hall at the Prime Minister's Office, at Christiansborg in Copenhagen, on January 10, 2025.
Leadership

Novo Nordisk CEO attends crisis talks with Danish PM amid Donald Trump Greenland threats

By
January 17, 2025
Elon Musk admits he takes an Ozempic-like weight-loss drug that RFK Jr. wants to restrict
Health

Elon Musk admits he takes an Ozempic-like weight-loss drug that RFK Jr. wants to restrict

By
December 27, 2024
Novo Nordisk advertising flags and logo on facade, Danish pharmaceutical healthcare giant Novo Nordisk AS, production innovative drugs, obesity treatment Ozempic, Mainz, Germany June 15, 2024
Health

Novo Nordisk faces stock market bloodbath after weight-loss drug trial disappoints

By Ryan Hogg and AFP
December 20, 2024
Novo Nordisk invests $1.2 billion in new Danish factory to expand beyond insulin and weight-loss
Tech

Novo Nordisk invests $1.2 billion in new Danish factory to expand beyond insulin and weight-loss

By
December 16, 2024
Close-up of a patient administering a dose of Zepbound (tirzepatide)
Health

Zepbound vs. Wegovy: New clinical trial says this weight-loss medication sheds more pounds

By
December 4, 2024
Mads Krogsgaard Thomsen, chief executive officer of Novo Nordisk Foundation, during a panel session on day two of the World Economic Forum (WEF) in Davos, Switzerland, on Tuesday, May 24, 2022.
Health

Novo Nordisk Foundation CEO dismisses ‘Nokia risk’ as ‘fundamentally different’ for Denmark’s economy

By
November 26, 2024
Novo Nordisk launches Wegovy in China with prices well below U.S.
Health

Novo Nordisk launches Wegovy in China with prices well below U.S.

By Amber Tong and Bloomberg
November 18, 2024
Novo Nordisk’s Wegovy sales jump on international rollouts
Retail

Novo Nordisk’s Wegovy sales jump on international rollouts

By Naomi Kresge and Bloomberg
November 6, 2024
Many hundred of spectators watch Queen Margrethe of Denmark while the Royal Guard takes her through the city of Kalundborg in a coach during her visit to the city where she commence a two days visit on June 13, 2017 in Kalundborg, Denmark.
Lifestyle

Danish manufacturing hub of weight-loss wonderdrug Ozempic is an epicenter for childhood overweightedness

By
November 4, 2024
A hand is seen holding Ozempic.
Health

Novo’s main Ozempic plant cited for quality lapses by FDA

By Madison Muller and Bloomberg
October 29, 2024
Despite the ubiquitousness of injectable GLP-1 drugs indicated for people with obesity, most Americans wouldn’t take them, according to a September 2024 survey from the Physicians Committee for Responsible Medicine.
Health

Most Americans who want to lose weight don’t want to take GLP-1 drugs like Wegovy and Zepbound, new survey says

By
October 10, 2024
Ozempic goes from threat to opportunity for packaged-food makers
Health

Ozempic goes from threat to opportunity for packaged-food makers

By Deena Shanker and Bloomberg
October 2, 2024
A person holds up a box of Ozempic.
Health

Ozempic may help manage opioid addiction: study

By Naomi Kresge and Bloomberg
September 25, 2024

Most Popular